» Articles » PMID: 26780748

Contrast-Induced Acute Kidney Injury: An Update

Overview
Date 2016 Jan 19
PMID 26780748
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

Contrast-induced acute kidney injury (CI-AKI) is defined as an abrupt deterioration in renal function associated with the administration of iodinated contrast media. This type of acute kidney injury is frequently encountered as a complication of percutaneous coronary intervention (PCI) and is associated with adverse short- and long-term outcomes including mainly mortality, cardiovascular morbidity and prolongation of hospitalization. The incidence of CI-AKI after PCI ranges from 2 to 20 % according to baseline kidney function. It may also range according to the clinical setting, being higher after emergency PCI. The primary manifestation is a small decline in kidney function, occurring 1 to 3 days after the procedure. Kidney function usually returns to preexisting levels within 7 days. Incidence of acute renal failure requiring dialysis following PCI is rare (<1 %). The present article aims to review up-to-date published data concerning diagnosis, definition, epidemiology and prognosis of this novel in-hospital epidemic.

Citing Articles

The triglyceride-glucose index and acute kidney injury risk in critically ill patients with coronary artery disease.

Zhang Y, Li G, Li J, Jian B, Wang K, Chen J Ren Fail. 2025; 47(1):2466818.

PMID: 39972619 PMC: 11843639. DOI: 10.1080/0886022X.2025.2466818.


Efficacy and safety of nicorandil for prevention of contrast-induced nephropathy in patients undergoing coronary procedures: a systematic review and meta-analysis.

Butt A, Afzal F, Raza S, Namal F, Ahmed D, Abid H Int Urol Nephrol. 2025; .

PMID: 39937383 DOI: 10.1007/s11255-025-04409-1.


Short-term effects of empagliflozin on preventing contrast induced acute kidney injury in patients undergoing percutaneous coronary intervention, a randomised trial.

Hosseini Z, Jamili M, Ensan B, Donyadideh G, Shahri B, Eshraghi H Sci Rep. 2025; 15(1):3940.

PMID: 39890841 PMC: 11785941. DOI: 10.1038/s41598-024-82991-7.


Sodium-glucose cotransporter 2 inhibitors in patients with type 2 diabetes and myocardial infarction undergoing percutaneous coronary intervention: A systematic review and meta-analysis.

Ansari H, Samad M, Mahboob E, Zulfiqar E, Qazi S, Ahsan A Am J Prev Cardiol. 2025; 21:100927.

PMID: 39867488 PMC: 11757226. DOI: 10.1016/j.ajpc.2024.100927.


Impact of iodinated contrast shortage on contrast-associated acute kidney injury: a single center experience.

Al-Azizi K, Moubarak G, Szerlip M, Kluis A, Kazem A, Bennett M Proc (Bayl Univ Med Cent). 2024; 37(2):218-226.

PMID: 38343489 PMC: 10857662. DOI: 10.1080/08998280.2023.2296692.